Abstract
The Russian pharmaceutical market is one of the fastest growing in the world. Its value is predicted to rise from $24 billion in 2013 to $75 billion by 2020 (1). For industry the market opportunity is compelling, however market access across this vast region is complex and challenging, specifically for high-cost products. This research was conducted to have a closer look at the Russian pharmaceutical pricing and reimbursement model, and further explore access barriers The research was conducted through in-depth secondary research and interviews with stakeholders in Russia including members of the Russian ministry of health, Federal health insurance fund, and regional/municipal health authorities. At the federal level, the Ministry of Health and Social Development (MoHSD) develops strategy, policy and budgets in health care. The MoHSD has developed an Essential Drugs List (EDL) to ensure that drugs are made available at a harmonized price across Russia. However being listed on the EDL does not ensure reimbursement. In Russia, regional health authorities function as independent units. Drug provision and systems of reimbursement are usually developed at a regional level. However, each of the 82 Russian regions also has fundamentally different demographic and economic conditions, creating unique requirements and subsequent disparity in health care delivery and funding across the regions. It is critical for manufacturers to get their product listed in individual regional formularies, which will be used as the foundation for the reimbursement systems as they are rolled out in the future. The Russian market is vast, fast growing and clearly offers massive opportunities for pharmaceutical companies. However, this is a complex market, with a considerable regional variation in decision making. Industry will have to invest in gaining regional insight to determine priority regions and justify market access plans according to the dynamics of a specific region.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
